BTLA and B-cell chronic lymphocytic leukemia: Consistent with this suggestion, when considering the impact of miR-155-5p inhibition on BTLA protein expression in T cells, we did not observe any significant changes in the BTLA levels of all individuals studied, which strengthens our hypothesis on the unaffected level of miR-155-5p in CLL T cells.